By Michele Maatouk
Date: Monday 21 Dec 2020
(Sharecast News) - Agios Pharmaceuticals said on Monday that it has agreed to sell its commercial, clinical and research-stage oncology portfolio to independent global pharmaceutical company Servier for as much as $2bn.
No recent information was found.
Currency | US Dollars |
Share Price | $ 38.20 |
Change Today | $ 1.38 |
% Change | 3.75 % |
52 Week High | $61.64 |
52 Week Low | $25.90 |
Volume | 460,891 |
Shares Issued | 58.68m |
Market Cap | $2,241.60m |
Beta | 0.01 |
RiskGrade | 304 |
Strong Buy | 1 |
Buy | 3 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 8 |
Time | Volume / Share Price |
16:00 | 78,001 @ $38.20 |
15:59 | 180 @ $38.21 |
15:59 | 100 @ $38.21 |
15:59 | 121 @ $38.16 |
15:59 | 100 @ $38.16 |
You are here: research